BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

SMA Newborn Screening and Early Intervention

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Friday, October 25, 2019
Sponsor Information: 

This activity has received an educational grant from AveXis Inc.

Faculty

David Dredge, MD
Co-Director, Massachusetts General Hospital Pediatric Neuromuscular Clinic
SMA Newborn Screening and Early Intervention
Activity Overview: 

This webinar about spinal muscular atrophy (SMA) and the potential benefits of early identification and treatment will provide practical advice on the management and coordination of care for SMA cases that are identified through newborn screening programs, including a treatment algorithm.